RGEN - Repligen Corporation

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

Pre-Market Stock Futures: Futures are trading mixed, with the Nasdaq getting hammered after a gangbuster start to the first full trading week of the third quarter. All of the major indices finished the day higher, with chip stocks once again leading the way. When the dust settled at the close, the Nasdaq finished the day... Here Are Tuesday's Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

Jul 07, 2026 04:00 AM • 247wallst.com

A Look at Repligen Corp (RGEN) After 4.9% Gain -- GF Value $175.89 vs Price $145.23

On June 25, 2026, Repligen Corp (RGEN) shares rose 4.9% to a current price of $145.23. The stock has experienced a 52-week range between $100.99 and $175.77, in

Jun 25, 2026 02:46 PM • gurufocus.com

Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tells Investors

On June 22, 2026, Repligen Corp (RGEN) shares fell 4.1% today, bringing the current price to $126.67. The stock has seen a 52-week range of $100.99 to $175.77,

Jun 22, 2026 04:09 PM • gurufocus.com

Repligen Corp (RGEN) Shares Surge 3.8% -- What GF Score of 83 Tells Investors

On June 09, 2026, Repligen Corp (RGEN) shares rose 3.8% today, closing at $130.10. The stock has fluctuated within a 52-week range of $100.99 to $175.77, indica

Jun 09, 2026 03:58 PM • gurufocus.com

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?

Jun 04, 2026 08:35 AM • zacks.com

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

During the first quarter of 2026, the largest portfolio sector weightings were Health Care and Industrials. RBC Bearings Incorporated, Cognex Corporation and Nebius Group were among the top contributors to performance. Repligen Corporation, Agilysys, Inc., and GeneDx Holdings Corp. were among the top detractors from performance.

Jun 04, 2026 08:15 AM • seekingalpha.com

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Jun 03, 2026 02:21 PM • seekingalpha.com

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen Has A Cleaner Recovery Angle, But With High Valuation

May 31, 2026 05:15 AM • seekingalpha.com

Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF Score: 79/100

On May 28, 2026, Repligen Corp (RGEN) shares rose 8.4% today, bringing the current price to $122.73. The stock has experienced volatility over the past year, tr

May 28, 2026 02:47 PM • gurufocus.com

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair 46th Annual Growth Stock Conference in Chicago, IL. Olivier Loeillot, President and Chief Executive Officer, will present a company overview on June 3rd at 10:40 a.m. CT.

May 22, 2026 03:30 AM • globenewswire.com

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate Sustainability Report and related reporting framework disclosures. Themed “Driving Sustainable Growth Together”, this report communicates the company's progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities, and Pathways to Success. Also included in the 2025 Sustainability Report are detailed disclosures aligned with the United Nations Sustainable Development Goals (UN SDGs) and three key reporting frameworks: the Global Reporting Initiative (GRI) Standards, Sustainability Accounting Standards Board (SASB) Standards and the Task Force on Climate-related Financial Disclosures (TCFD), now part of the IFRS Sustainability Alliance.

May 20, 2026 03:30 AM • globenewswire.com

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 12, 2026 12:11 PM • seekingalpha.com

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Bank of America Securities 2026 Global Healthcare Conference, being held May 12-14 in Las Vegas, Nevada.

May 07, 2026 03:30 AM • globenewswire.com

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its 2026 EPS view.

May 06, 2026 08:50 AM • zacks.com

Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript

Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript

May 05, 2026 10:41 AM • seekingalpha.com

Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates

Repligen (RGEN) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.39 per share a year ago.

May 05, 2026 06:15 AM • zacks.com

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026.

May 05, 2026 03:00 AM • globenewswire.com

Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apr 30, 2026 07:01 AM • zacks.com

Alger Mid Cap Growth Fund Q1 2026 Portfolio Review

Class A shares of the Alger Mid Cap Growth Fund underperformed the Russell Midcap Growth Index during the first quarter of 2026. FTAI Aviation Ltd., Vertiv Holdings Co. and Comfort Systems USA, Inc., were among the top contributors to performance. Repligen Corporation, AppLovin Corp., and Carvana Co. were among the top detractors from performance.

Apr 29, 2026 12:10 AM • seekingalpha.com

Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for

Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apr 28, 2026 07:06 AM • zacks.com

Repligen price target raised to $160 from $150 at Evercore ISI

$160.00 (was $139.37)

Evercore ISI

Jul 06, 2026 08:47 AM • TheFly

Repligen resumed with an Outperform at RBC Capital

$160.00 (was $103.38)

Dan Leonard · RBC Capital

May 14, 2026 04:19 PM • TheFly

Repligen price target lowered to $142 from $152 at Jefferies

$142.00 (was $125.61)

Matthew Stanton · Jefferies

May 05, 2026 03:44 PM • TheFly

Repligen price target lowered to $145 from $165 at Canaccord

$145.00 (was $132.19)

Canaccord Genuity

Apr 20, 2026 09:03 AM • TheFly

Repligen initiated with a Buy at Rothschild & Co Redburn

$160.00 (was $127.09)

Redburn Partners

Apr 17, 2026 04:48 AM • TheFly

Repligen price target lowered to $145 from $175 at Barclays

$145.00 (was $122.59)

Luke Sergott · Barclays

Apr 14, 2026 06:43 AM • TheFly

Repligen price target raised to $200 from $190 at UBS

$200.00 (was $161.69)

Dan Leonard · UBS

Jan 16, 2026 07:18 AM • TheFly

Repligen price target raised to $190 from $175 at Wells Fargo

$190.00 (was $157.33)

Wells Fargo

Dec 15, 2025 06:29 AM • TheFly

Repligen price target raised to $200 from $175 at Barclays

$200.00 (was $157.33)

Barclays

Dec 15, 2025 05:56 AM • TheFly

Repligen price target raised to $165 from $150 at Canaccord

$165.00 (was $151.57)

Canaccord Genuity

Oct 29, 2025 06:58 AM • TheFly

Repligen price target raised to $175 from $160 at Barclays

$175.00 (was $151.57)

Barclays

Oct 29, 2025 05:35 AM • TheFly

Repligen (RGEN) PT Raised to $160 at Jefferies

$160.00 (was $154.24)

Matthew Stanton · Jefferies

Oct 28, 2025 01:41 PM • StreetInsider

Repligen price target raised to $160 from $150 at Barclays

$160.00 (was $145.81)

Luke Sergott · Barclays

Oct 02, 2025 06:44 AM • TheFly

Repligen initiated with a Buy at HSBC

$150.00 (was $133.67)

HSBC

Oct 01, 2025 04:45 AM • TheFly

Repligen price target raised to $205 from $204 at RBC Capital

$205.00 (was $120.69)

RBC Capital

Sep 02, 2025 05:01 PM • TheFly

KeyBanc Reiterates Overweight Rating on Repligen (RGEN)

$220.00 (was $148.59)

Paul Knight · KeyBanc

Nov 12, 2024 02:45 PM • StreetInsider

These Analysts Revise Their Forecasts On Repligen Following Q2 Results

$200.00 (was $167.35)

Rachel Vatnsdal · J.P. Morgan

Jul 31, 2024 10:50 AM • Benzinga

These Analysts Revise Their Forecasts On Repligen Following Q2 Results

$185.00 (was $167.35)

Elizabeth Garcia · UBS

Jul 31, 2024 10:50 AM • Benzinga

Deutsche Bank Upgrades Repligen (RGEN) to Buy

$155.00 (was $127.00)

Justin Bowers · Deutsche Bank

Jun 26, 2024 02:12 AM • StreetInsider

Stifel Out Positive on Repligen (RGEN): 'current levels seem as though they will have proven to be good ones'

$207.00 (was $123.16)

Daniel Arias · Stifel Nicolaus

Jun 21, 2024 08:12 AM • StreetInsider